JOINT FILING AGREEMENTJoint Filing Agreement • February 17th, 2009 • Aphton CORP • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 17th, 2009 Company IndustryIn accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to 3,627,350 shares of Common Stock of Aphton Corporation and further agree that this Joint Filing Agreement shall be included as an exhibit to such joint filings.